Practica oto-rhino-laryngologica. Suppl.
Online ISSN : 2185-1557
Print ISSN : 0912-1870
ISSN-L : 0912-1870
Search
Advanced search
OR
Browse
Search
Volume 2003, Issue Supplement112
Displaying 1-1 of 1 articles from this issue
Show all abstracts
    • |<
    • <
    • 1
    • >
    • >|
  • An Open Clinical Trial of an Antithrombotic Drug, Ecbarl® in Elderly Dizziness Patients
    Takashi Futaki
    2003 Volume 2003 Issue Supplement112 Pages 1-16
    Published: July 01, 2003
    Released on J-STAGE: November 27, 2012
    DOIhttps://doi.org/10.5631/jibirinsuppl1986.2003.Supplement112_1
    JOURNAL FREE ACCESS
    Show abstractHide abstract
    Cilostazol ( Ecbarl®)a, n antiplatelet drug, has widely been used in chronic arterial occulusive disease. In addition, it has been reported that Ecbar® has another beneficial effect, it selectivery increase blood flow in the vertebro-basilar artery.
    The symptoms of vertigo, dizziness or unsteadiness are mainly and closely linked to disorder of the blood flow in the vertebral arteries. In order to examine the clinical effects of this drug, I employed an open trial of 20 elderly patients with dizziness who were administrated Ecbarl®for 4 weeks at 100 mg or 200 mg a day.
    Before and after the clinical trial, not only subjective symptoms but also the objective data obtained mainly through the electronystagmo-graphic recordings were examined by statistical procedures.
    Both results yielded significantly good without any side effect.
    View full abstract
    Download PDF (3123K)
    • |<
    • <
    • 1
    • >
    • >|
feedback
 Top